Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1963 1
1984 1
1987 2
1989 1
1990 1
1991 1
1992 1
1993 1
1996 6
1997 5
1998 6
1999 3
2000 2
2001 7
2002 6
2003 11
2004 19
2005 22
2006 20
2007 22
2008 25
2009 32
2010 41
2011 32
2012 32
2013 37
2014 35
2015 45
2016 45
2017 35
2018 40
2019 40
2020 51
2021 49
2022 45
2023 33
2024 39
2025 37

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

714 results

Results by year

Filters applied: . Clear all
Page 1
C3 glomerulopathy - understanding a rare complement-driven renal disease.
Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM. Smith RJH, et al. Among authors: kavanagh d. Nat Rev Nephrol. 2019 Mar;15(3):129-143. doi: 10.1038/s41581-018-0107-2. Nat Rev Nephrol. 2019. PMID: 30692664 Free PMC article. Review.
Thrombotic Microangiopathy and the Kidney.
Brocklebank V, Wood KM, Kavanagh D. Brocklebank V, et al. Among authors: kavanagh d. Clin J Am Soc Nephrol. 2018 Feb 7;13(2):300-317. doi: 10.2215/CJN.00620117. Epub 2017 Oct 17. Clin J Am Soc Nephrol. 2018. PMID: 29042465 Free PMC article. Review.
Diagnosis and treatment of thrombotic microangiopathy.
Thompson GL, Kavanagh D. Thompson GL, et al. Among authors: kavanagh d. Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):101-113. doi: 10.1111/ijlh.13954. Int J Lab Hematol. 2022. PMID: 36074708 Free PMC article. Review.
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodríguez de Córdoba S, Roumenina LT, Sethi S, Smith RJ; Conference Participants. Goodship TH, et al. Among authors: kavanagh d. Kidney Int. 2017 Mar;91(3):539-551. doi: 10.1016/j.kint.2016.10.005. Epub 2016 Dec 16. Kidney Int. 2017. PMID: 27989322 Free article.
Post-transplant Thrombotic Microangiopathy.
Java A, Sparks MA, Kavanagh D. Java A, et al. Among authors: kavanagh d. J Am Soc Nephrol. 2025 May 1;36(5):940-951. doi: 10.1681/ASN.0000000645. Epub 2025 Jan 31. J Am Soc Nephrol. 2025. PMID: 39888686 Review.
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Wong E, Nester C, Cavero T, Karras A, Le Quintrec M, Lightstone L, Eisenberger U, Soler MJ, Kavanagh D, Daina E, Praga M, Medjeral-Thomas NR, Gäckler A, Garcia-Carro C, Biondani A, Chaperon F, Kulmatycki K, Milojevic J, Webb NJA, Nidamarthy PK, Junge G, Remuzzi G. Wong E, et al. Among authors: kavanagh d. Kidney Int Rep. 2023 Sep 22;8(12):2754-2764. doi: 10.1016/j.ekir.2023.09.017. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106570 Free PMC article.
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Among authors: kavanagh d. Kidney Int. 2020 Jun;97(6):1287-1296. doi: 10.1016/j.kint.2020.01.035. Epub 2020 Mar 6. Kidney Int. 2020. PMID: 32299680 Free article. Clinical Trial.
714 results